801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsSmall Volume Parenteral

Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy

Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy

  • Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy
Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy
Product Details:
Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 150mg:3ml
Payment & Shipping Terms:
Minimum Order Quantity: 100, 000 vials
Price: Negotiation
Packaging Details: one vial/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: 300, 000 vials per day
Contact Now
Detailed Product Description
Product: Medroxyprogesterone Acetate Injection Specification: 150mg:3ml
Standard: USP Packing: One Vial/box
High Light:

small volume injection

,

lyophilized injection

Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy

 

 

Product : Medroxyprogesterone Acetate Injection

Specification : 150mg:3ml

Standard : USP

Packing : one vial/box

 

Description :

Medroxyprogesterone Acetate Injectable Suspension, USP contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off-white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.

Medroxyprogesterone Acetate Injectable Suspension, USP for intramuscular (IM) injection is available in vials, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.

 

Indications and Usage :

Medroxyprogesterone Acetate Injectable Suspension, USP is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, in the risk/benefit assessment for women who use Medroxyprogesterone Acetate Injectable Suspension, USP long-term.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Luke Liu

Tel: +8618067597692

Send your inquiry directly to us (0 / 3000)

Other Products